Quality assurance is a wide-ranging concept encompassing all factors that collectively influence the quality attributes of medical products.
The development of generic versions of innovator medicines is a global public health need.
When it comes to good distribution practices (GDPs) for medical products, patient safety is the highest priority, panelists affirmed during an April 26 session of the Asia-Pacific Economic Cooperation (APEC) forum’s
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for the 76th meeting of the World Health Assembly (WHA), the decision-making body of the World Health Organization (WHO).
Many patients and consumers have a mental picture of the last leg of the pharmaceutical supply chain as a neighborhood drug store where they pick up their prescriptions. The advent of the Internet age, however, renders that picture incomplete at best.
After Laura Bray’s daughter was diagnosed with cancer and began chemotherapy treatment, she faced three separate shortages of the life-saving drugs she needed, all within nine months.
Innovation and standardization across borders are essential to facilitate manufacturing solutions that can strengthen the global medicines supply chain, panelists suggested during an April 25 session of the Asia-Pacific Economic Cooperation (APEC